University of Washington
Seattle, Washington, 98103, United States
NCT Number: NCT00461877
The purpose of this study is to determine risk factors for HPV infections in 25 to 65 year old women who report having used internet dating websites in the past year.
Looking for future studies?
Notify Me25 year–65 year
Female
Observational
Seattle, Washington, 98103, United States
Whether older women are susceptible to acquiring new, persistent high-risk (HR) HPV infections from new sex partners is largely unknown. This is a pilot study of predictors of HR HPV infections in two populations of women aged 25 to 44 and 45 to 65 who have used internet dating websites in the past year. 400 women will be recruited and mailed kits for self-collecting vaginal specimens for HPV DNA testing. Women will self-collect two sets of vaginal specimens four months apart, and complete sexual behavior questionnaires at the time of each self-collection. If new HPV infections associated with recent new partners are detected in these women, this pilot data will be used to develop a larger longitudinal study of the acquisition and natural history of HR HPV infections in older women. This information is important for developing guidelines for HPV vaccine implementation and cervical cancer screening guidelines in populations of older women.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: four months
University of Washington
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04072913
Cervix Cancer, Communicable Diseases
Bordeaux, France
View Trial DetailsNCT03903562
Communicable Diseases, DNA Virus Infections
Quzhou, Zhejiang, China
View Trial DetailsNCT06919627
Cervical Cancers, Communicable Diseases
Brest, Brittany Region, France
View Trial DetailsNCT02858310
Carcinoma, Carcinoma in Situ
Bethesda, Maryland, United States
View Trial Details